The independent source for health policy research, polling, and news.
401 - 420 of 547 Results
A seedy section of downtown Los Angeles has become the go-to place for those who trade in wholesale — and sometimes counterfeit — vaping products. As more people fall ill with a mysterious lung disease linked to e-cigarette use, the manufacture and distribution of vaping products face increased scrutiny.
The technology for vaping has changed over the years, and researchers are finding more evidence that the way vaping devices and e-liquids interact could harm consumers.
In response to the crackdowns on vaping, those who use or sell the e-cigarette products are mobilizing. Touting the “We Vape, We Vote” slogan, this burgeoning movement is positioning itself to be a factor in 2020 elections.
The number of U.S. infants who acquired syphilis from their mothers during pregnancy rose 40% last year. Just five states, including California, accounted for nearly two-thirds of the cases.
With federal authorities offering few details about what is causing the deadly outbreak of vaping-related lung illnesses, vaping advocates are crafting an alternative narrative reverberating through online communities.
Without the teamwork, communication and quick action of several veteran health officials in Wisconsin, the world might not know about the vaping illness the U.S. is battling today. This is their story.
A hearing before a House Oversight and Reform Committee panel on how to address the crisis of respiratory injuries related to vaping turned surprisingly partisan.
Passengers on massive cruise ships could be struck by norovirus or accidents ranging from falls to broken bones. Then what?
Sen Bernie Sanders' statement during Thursday night's Democratic debate serves up interesting data, with a side of misrepresentation.
California Healthline reporter Ana Ibarra appeared Monday on WNYC to discuss the recent outbreak of mysterious lung diseases related to vaping, including 60 possible cases in California.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Doctors who saw patients with a mysterious lung illness in the past suspected vaping as the cause but didn’t know where to report such cases.
In the wake of the opioid crisis, the highly communicable hepatitis A virus is spreading in more than half the states and making its way into the general public. Underfunded health officials are valiantly trying to fight it with vaccines.
The recent tragic mass shootings have refocused efforts to treat gun violence as a public health issue rather than strictly a law enforcement problem. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Agnes Carey of Kaiser Health News join KHN’s Julie Rovner to discuss this, plus the health implications of the budget deal passed by Congress and signed by President Donald Trump, as well as reaction from Canada to a proposal to allow broader imports of its prescription drugs. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
A federal advisory panel says people between ages 27 and 45 may benefit from the vaccine to fight the human papillomavirus. But some public health advocates worry that the advice doesn’t provide doctors and patients clear guidance about who in this large age group are good candidates for the vaccine.
Doctors should assess older adults for the risk of falling, come up with individualized plans and refer seniors to physical therapists, occupational therapists and evidence-based programs.
The federal government has doled out at least $2.4 billion in state grants since 2017 to address the opioid epidemic, which killed 47,600 people in the U.S. that year alone. But local officials note that drug abuse problems seldom involve only one substance.
As people advance in age, the expectations for what constitutes good health change. People focus on positive emotions and satisfaction with life, while physical ailments play a less important role.
New data from the California agency that manages health benefits for 1.5 million public employees, retirees and their families shows that doctors are writing far fewer opioid prescriptions, reflecting a national trend of physicians cutting back on the addictive drugs.
For the seventh year in a row, Missouri will retain its lonely title as the only state without a statewide prescription drug monitoring program. Fears about privacy violations and gun control scuttled the bill yet again, leaving a pastiche of half-step measures in place to fill the void in the fight against prescription drug abuse.
© 2026 KFF